ATA539376A - Verfahren zur herstellung von neuen 11,12- ungesaettigten 9alpha-fluorsteroiden - Google Patents
Verfahren zur herstellung von neuen 11,12- ungesaettigten 9alpha-fluorsteroidenInfo
- Publication number
- ATA539376A ATA539376A AT539376A AT539376A ATA539376A AT A539376 A ATA539376 A AT A539376A AT 539376 A AT539376 A AT 539376A AT 539376 A AT539376 A AT 539376A AT A539376 A ATA539376 A AT A539376A
- Authority
- AT
- Austria
- Prior art keywords
- fluoresteroids
- 9alpha
- unsaturated
- producing new
- producing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
- C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
- C07J7/009—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by only one oxygen atom doubly bound
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/0026—Oxygen-containing hetero ring cyclic ketals
- C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH962075A CH611631A5 (en) | 1975-07-23 | 1975-07-23 | Process for the preparation of 11,12-unsaturated 9alpha-fluorosteroids |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ATA539376A true ATA539376A (de) | 1979-05-15 |
| AT353989B AT353989B (de) | 1979-12-10 |
Family
ID=4353884
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT539376A AT353989B (de) | 1975-07-23 | 1976-07-22 | Verfahren zur herstellung von neuen 11,12- ungesaettigten 9alpha-fluorsteroiden |
Country Status (15)
| Country | Link |
|---|---|
| JP (1) | JPS5214761A (de) |
| AT (1) | AT353989B (de) |
| AU (1) | AU505846B2 (de) |
| BE (1) | BE844378A (de) |
| CH (1) | CH611631A5 (de) |
| DE (1) | DE2632550A1 (de) |
| DK (1) | DK329976A (de) |
| ES (1) | ES449989A1 (de) |
| FR (1) | FR2318644A1 (de) |
| GB (1) | GB1520356A (de) |
| IE (1) | IE43926B1 (de) |
| NL (1) | NL7608141A (de) |
| NZ (1) | NZ181538A (de) |
| SE (1) | SE7608369L (de) |
| ZA (1) | ZA764405B (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5423643A (en) * | 1977-07-22 | 1979-02-22 | Aikawa Tekko | Doctor blade stablizing apparatus |
| DE3069074D1 (en) * | 1979-11-16 | 1984-10-04 | Sterosynt Ltd | 6-alpha-9-alpha-difluoro-16-beta-methyl-prednisolone-17,21 diesters and pharmaceutical compositions containing them |
| FI911202A (fi) * | 1990-12-28 | 1992-06-29 | Albany Int Corp | Schaberblad. |
-
1975
- 1975-07-23 CH CH962075A patent/CH611631A5/xx not_active IP Right Cessation
-
1976
- 1976-07-20 DE DE19762632550 patent/DE2632550A1/de active Pending
- 1976-07-21 FR FR7622212A patent/FR2318644A1/fr active Granted
- 1976-07-21 ES ES449989A patent/ES449989A1/es not_active Expired
- 1976-07-22 IE IE1623/76A patent/IE43926B1/en unknown
- 1976-07-22 NZ NZ181538A patent/NZ181538A/xx unknown
- 1976-07-22 AU AU16121/76A patent/AU505846B2/en not_active Expired
- 1976-07-22 BE BE169116A patent/BE844378A/xx unknown
- 1976-07-22 GB GB30616/76A patent/GB1520356A/en not_active Expired
- 1976-07-22 DK DK329976A patent/DK329976A/da unknown
- 1976-07-22 AT AT539376A patent/AT353989B/de not_active IP Right Cessation
- 1976-07-22 ZA ZA764405A patent/ZA764405B/xx unknown
- 1976-07-22 NL NL7608141A patent/NL7608141A/xx not_active Application Discontinuation
- 1976-07-22 SE SE7608369A patent/SE7608369L/xx unknown
- 1976-07-23 JP JP51087371A patent/JPS5214761A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| FR2318644A1 (fr) | 1977-02-18 |
| IE43926L (en) | 1977-01-23 |
| AU505846B2 (en) | 1979-12-06 |
| NL7608141A (nl) | 1977-01-25 |
| BE844378A (fr) | 1977-01-24 |
| DE2632550A1 (de) | 1977-02-10 |
| DK329976A (da) | 1977-01-24 |
| FR2318644B1 (de) | 1978-12-15 |
| SE7608369L (sv) | 1977-01-24 |
| ZA764405B (en) | 1977-08-31 |
| AU1612176A (en) | 1978-01-26 |
| AT353989B (de) | 1979-12-10 |
| JPS5214761A (en) | 1977-02-03 |
| NZ181538A (en) | 1978-09-20 |
| ES449989A1 (es) | 1977-12-01 |
| IE43926B1 (en) | 1981-07-01 |
| CH611631A5 (en) | 1979-06-15 |
| GB1520356A (en) | 1978-08-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT360663B (de) | Verfahren zur herstellung von neuen 6,7- -benzomorphanen | |
| AT366374B (de) | Verfahren zur herstellung von neuen n3substituierten 5,5-dimethylhydantoinen | |
| ATA81279A (de) | Verfahren zur herstellung von neuen 9alpha,21- -dihalogen-11beta,17alpha-dihydroxy-6alpha- -fluor-16alpha-methyl-pregna-1,4-dien-3,20-dion -verbindungn | |
| AT342045B (de) | Verfahren zur herstellung von neuen 1,1-diaryl-1-oxadiazolalkylaminen | |
| AT344896B (de) | Verfahren zur herstellung von neuen piperazinyliminorifamycinen | |
| AT349633B (de) | Verfahren zur herstellung von neuen dauno- saminylanthracylcinonen | |
| AT356671B (de) | Verfahren zur herstellung von neuen n,n'-thio- -di-carbamaten | |
| AT353956B (de) | Verfahren zur herstellung von neuen cephalosporinantibiotika | |
| ATA585876A (de) | Verfahren zur herstellung von neuen 2-benzimidazolylcarbamaten | |
| AT354434B (de) | Verfahren zur herstellung von neuen 1,4- diphenyl-3-pyrazolin-5-onen | |
| AT341540B (de) | Verfahren zur herstellung von neuen 1,3-dialkyl-7-aminoalkylxanthinen | |
| ATA151379A (de) | Verfahren zur herstellung von neuen 9alpha,21- dihalogen-11beta,17alpha-dihydroxy-6alpha-fluor -16beta-methyl-pregna-1,4-dien-verbindungen | |
| ATA454376A (de) | Verfahren zur herstellung von neuen 2,6-dinitro-3-azido-4-trifluormethylanilinen und -hydrazinen | |
| AT345780B (de) | Verfahren zur herstellung von neuem 3,7- dimethyl-3-hydroxyoctannitril | |
| AT344150B (de) | Verfahren zur herstellung von neuen cyclohexylphenylen | |
| AT353989B (de) | Verfahren zur herstellung von neuen 11,12- ungesaettigten 9alpha-fluorsteroiden | |
| AT358575B (de) | Verfahren zur herstellung von neuen 2- carbalkoxyamino-5(6)-phenyl-sulfonyloxy- -benzimidazolen | |
| DD129214A5 (de) | Verfahren zur herstellung von neuen 1,9-dihydroxy-hexahydrodibenzopyranen | |
| AT353759B (de) | Verfahren zur herstellung von 1,2-dichloraethan | |
| AT341669B (de) | Verfahren zur herstellung von neuen 3,4-dicarboxycephalosporinen | |
| ATA418276A (de) | Verfahren zur herstellung von neuen, substituierten 1,2,4-oxadiazolidin-3-on-verbindungen | |
| AT345801B (de) | Verfahren zur herstellung von neuen 1-phenoxy- 2-acyloxy-3-amino-propanderivaten | |
| ATA491279A (de) | Verfahren zur herstellung von neuen 2,9-alpha- | |
| ATA81179A (de) | Verfahren zur herstellung von neuen 9alpha, 21- -dihalogen-11beta, 17alpha-dihydroxy-6alpha- -fluor-16alpha-methyl-pregna-1,4-dien-3-20- -dion-verbindungen | |
| AT342617B (de) | Verfahren zur herstellung von neuen 1-methyl-3-alkyl-7-oxoalkylxanthinen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ELJ | Ceased due to non-payment of the annual fee |